{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T04:15:12Z","timestamp":1773980112671,"version":"3.50.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s13014-016-0673-z","type":"journal-article","created":{"date-parts":[[2016,8,2]],"date-time":"2016-08-02T09:20:26Z","timestamp":1470129626000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Re-irradiation for locoregionally recurrent tumors of the thorax: a single-institution, retrospective study"],"prefix":"10.1186","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3478-5681","authenticated-orcid":false,"given":"Kiyomi","family":"Sumita","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideyuki","family":"Harada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirofumi","family":"Asakura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirofumi","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsuyoshi","family":"Onoe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeyuki","family":"Murayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoaki","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noboru","family":"Tanigawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiaki","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuo","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,8,2]]},"reference":[{"key":"673_CR1","unstructured":"Agency for Research on Cancer, Worlf Health. [ http:\/\/globocan.iarc.fr\/pages\/fact_sheets_cancer.aspx ]. Accessed 6 Apr 2016."},{"key":"673_CR2","doi-asserted-by":"crossref","first-page":"723","DOI":"10.7326\/0003-4819-125-9-199611010-00003","volume":"125","author":"RS Pritchard","year":"1996","unstructured":"Pritchard RS, Anthony SP. Chemotherapy plus radiotherapy compared with radiotherapy alone in the treatment of locally advanced, unresectable, non-small-cell lung cancer. A meta-analysis. Ann Intern Med. 1996;125:723\u20139.","journal-title":"Ann Intern Med"},{"key":"673_CR3","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1002\/1097-0142(19950815)76:4<593::AID-CNCR2820760409>3.0.CO;2-N","volume":"76","author":"P Marino","year":"1995","unstructured":"Marino P, Preatoni A, Cantoni A. Randomized trials of radiotherapy alone versus combined chemotherapy and radiotherapy in stages IIIa and IIIb nonsmall cell lung cancer. A meta-analysis. Cancer. 1995;76:593\u2013601.","journal-title":"Cancer"},{"key":"673_CR4","doi-asserted-by":"crossref","unstructured":"Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. Non-small Cell Lung Cancer Collaborative Group. Bmj. 1995;311:899\u2013909","DOI":"10.1136\/bmj.311.7010.899"},{"key":"673_CR5","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1056\/NEJM199212033272302","volume":"327","author":"JP Pignon","year":"1992","unstructured":"Pignon JP, Arriagada R, Ihde DC, Johnson DH, Perry MC, Souhami RL, Brodin O, Joss RA, Kies MS, Lebeau B, et al. A meta-analysis of thoracic radiotherapy for small-cell lung cancer. N Engl J Med. 1992;327:1618\u201324.","journal-title":"N Engl J Med"},{"key":"673_CR6","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1200\/JCO.1992.10.6.890","volume":"10","author":"P Warde","year":"1992","unstructured":"Warde P, Payne D. Does thoracic irradiation improve survival and local control in limited-stage small-cell carcinoma of the lung? A meta-analysis. J Clin Oncol. 1992;10:890\u20135.","journal-title":"J Clin Oncol"},{"key":"673_CR7","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1200\/JCO.2009.26.2543","volume":"28","author":"A Auperin","year":"2010","unstructured":"Auperin A, Le Pechoux C, Rolland E, Curran WJ, Furuse K, Fournel P, Belderbos J, Clamon G, Ulutin HC, Paulus R, et al. Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer. J Clin Oncol. 2010;28:2181\u201390.","journal-title":"J Clin Oncol"},{"key":"673_CR8","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1056\/NEJM199901283400403","volume":"340","author":"AT Turrisi 3rd","year":"1999","unstructured":"Turrisi 3rd AT, Kim K, Blum R, Sause WT, Livingston RB, Komaki R, Wagner H, Aisner S, Johnson DH. Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide. N Engl J Med. 1999;340:265\u201371.","journal-title":"N Engl J Med"},{"key":"673_CR9","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1200\/JCO.2000.18.10.2095","volume":"18","author":"FA Shepherd","year":"2000","unstructured":"Shepherd FA, Dancey J, Ramlau R, Mattson K, Gralla R, O\u2019Rourke M, Levitan N, Gressot L, Vincent M, Burkes R, et al. Prospective randomized trial of docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy. J Clin Oncol. 2000;18:2095\u2013103.","journal-title":"J Clin Oncol"},{"key":"673_CR10","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1200\/JCO.2000.18.12.2354","volume":"18","author":"FV Fossella","year":"2000","unstructured":"Fossella FV, DeVore R, Kerr RN, Crawford J, Natale RR, Dunphy F, Kalman L, Miller V, Lee JS, Moore M, et al. Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group. J Clin Oncol. 2000;18:2354\u201362.","journal-title":"J Clin Oncol"},{"key":"673_CR11","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1200\/JCO.2004.08.163","volume":"22","author":"N Hanna","year":"2004","unstructured":"Hanna N, Shepherd FA, Fossella FV, Pereira JR, De Marinis F, von Pawel J, Gatzemeier U, Tsao TC, Pless M, Muller T, et al. Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy. J Clin Oncol. 2004;22:1589\u201397.","journal-title":"J Clin Oncol"},{"key":"673_CR12","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/S0140-6736(05)67625-8","volume":"366","author":"N Thatcher","year":"2005","unstructured":"Thatcher N, Chang A, Parikh P, Rodrigues Pereira J, Ciuleanu T, von Pawel J, Thongprasert S, Tan EH, Pemberton K, Archer V, Carroll K. Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer). Lancet. 2005;366:1527\u201337.","journal-title":"Lancet"},{"key":"673_CR13","doi-asserted-by":"crossref","first-page":"4244","DOI":"10.1200\/JCO.2007.15.0185","volume":"26","author":"R Maruyama","year":"2008","unstructured":"Maruyama R, Nishiwaki Y, Tamura T, Yamamoto N, Tsuboi M, Nakagawa K, Shinkai T, Negoro S, Imamura F, Eguchi K, et al. Phase III study, V-15-32, of gefitinib versus docetaxel in previously treated Japanese patients with non-small-cell lung cancer. J Clin Oncol. 2008;26:4244\u201352.","journal-title":"J Clin Oncol"},{"key":"673_CR14","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1016\/S0140-6736(08)61758-4","volume":"372","author":"ES Kim","year":"2008","unstructured":"Kim ES, Hirsh V, Mok T, Socinski MA, Gervais R, Wu YL, Li LY, Watkins CL, Sellers MV, Lowe ES, et al. Gefitinib versus docetaxel in previously treated non-small-cell lung cancer (INTEREST): a randomised phase III trial. Lancet. 2008;372:1809\u201318.","journal-title":"Lancet"},{"key":"673_CR15","doi-asserted-by":"crossref","first-page":"5441","DOI":"10.1200\/JCO.2006.06.5821","volume":"24","author":"ME O\u2019Brien","year":"2006","unstructured":"O\u2019Brien ME, Ciuleanu TE, Tsekov H, Shparyk Y, Cucevia B, Juhasz G, Thatcher N, Ross GA, Dane GC, Crofts T. Phase III trial comparing supportive care alone with supportive care with oral topotecan in patients with relapsed small-cell lung cancer. J Clin Oncol. 2006;24:5441\u20137.","journal-title":"J Clin Oncol"},{"key":"673_CR16","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1200\/JCO.1999.17.2.658","volume":"17","author":"J Pawel von","year":"1999","unstructured":"von Pawel J, Schiller JH, Shepherd FA, Fields SZ, Kleisbauer JP, Chrysson NG, Stewart DJ, Clark PI, Palmer MC, Depierre A, et al. Topotecan versus cyclophosphamide, doxorubicin, and vincristine for the treatment of recurrent small-cell lung cancer. J Clin Oncol. 1999;17:658\u201367.","journal-title":"J Clin Oncol"},{"key":"673_CR17","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1200\/JCO.2006.08.3998","volume":"25","author":"JR Eckardt","year":"2007","unstructured":"Eckardt JR, von Pawel J, Pujol JL, Papai Z, Quoix E, Ardizzoni A, Poulin R, Preston AJ, Dane G, Ross G. Phase III study of oral compared with intravenous topotecan as second-line therapy in small-cell lung cancer. J Clin Oncol. 2007;25:2086\u201392.","journal-title":"J Clin Oncol"},{"key":"673_CR18","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/1097-0142(19820301)49:5<865::AID-CNCR2820490507>3.0.CO;2-H","volume":"49","author":"N Green","year":"1982","unstructured":"Green N, Melbye RW. Lung cancer: retreatment of local recurrence after definitive irradiation. Cancer. 1982;49:865\u20138.","journal-title":"Cancer"},{"key":"673_CR19","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.ijrobp.2011.01.069","volume":"80","author":"B Jeremic","year":"2011","unstructured":"Jeremic B, Videtic GM. Chest reirradiation with external beam radiotherapy for locally recurrent non-small-cell lung cancer: a review. Int J Radiat Oncol Biol Phys. 2011;80:969\u201377.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"673_CR20","doi-asserted-by":"crossref","first-page":"e620","DOI":"10.1016\/S1470-2045(14)70345-6","volume":"15","author":"D Ruysscher De","year":"2014","unstructured":"De Ruysscher D, Faivre-Finn C, Le Pechoux C, Peeters S, Belderbos J. High-dose re-irradiation following radical radiotherapy for non-small-cell lung cancer. Lancet Oncol. 2014;15:e620\u2013624.","journal-title":"Lancet Oncol"},{"key":"673_CR21","first-page":"75","volume":"3","author":"CS Drodge","year":"2014","unstructured":"Drodge CS, Ghosh S, Fairchild A. Thoracic reirradiation for lung cancer: a literature review and practical guide. Ann Palliat Med. 2014;3:75\u201391.","journal-title":"Ann Palliat Med"},{"key":"673_CR22","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.ctrv.2015.04.002","volume":"41","author":"B Bari De","year":"2015","unstructured":"De Bari B, Filippi AR, Mazzola R, Bonomo P, Trovo M, Livi L, Alongi F. Available evidence on re-irradiation with stereotactic ablative radiotherapy following high-dose previous thoracic radiotherapy for lung malignancies. Cancer Treat Rev. 2015;41:511\u20138.","journal-title":"Cancer Treat Rev"},{"key":"673_CR23","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.radonc.2013.11.017","volume":"110","author":"JM Kilburn","year":"2014","unstructured":"Kilburn JM, Kuremsky JG, Blackstock AW, Munley MT, Kearns WT, Hinson WH, Lovato JF, Miller AA, Petty WJ, Urbanic JJ. Thoracic re-irradiation using stereotactic body radiotherapy (SBRT) techniques as first or second course of treatment. Radiother Oncol. 2014;110:505\u201310.","journal-title":"Radiother Oncol"},{"key":"673_CR24","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/j.ijrobp.2014.01.012","volume":"88","author":"M Trovo","year":"2014","unstructured":"Trovo M, Minatel E, Durofil E, Polesel J, Avanzo M, Baresic T, Bearz A, Del Conte A, Franchin G, Gobitti C, et al. Stereotactic body radiation therapy for re-irradiation of persistent or recurrent non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 2014;88:1114\u20139.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"673_CR25","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1016\/j.ijrobp.2009.09.070","volume":"78","author":"P Kelly","year":"2010","unstructured":"Kelly P, Balter PA, Rebueno N, Sharp HJ, Liao Z, Komaki R, Chang JY. Stereotactic body radiation therapy for patients with lung cancer previously treated with thoracic radiation. Int J Radiat Oncol Biol Phys. 2010;78:1387\u201393.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"673_CR26","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.ijrobp.2012.02.020","volume":"84","author":"H Liu","year":"2012","unstructured":"Liu H, Zhang X, Vinogradskiy YY, Swisher SG, Komaki R, Chang JY. Predicting radiation pneumonitis after stereotactic ablative radiation therapy in patients previously treated with conventional thoracic radiation therapy. Int J Radiat Oncol Biol Phys. 2012;84:1017\u201323.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"673_CR27","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.radonc.2013.08.014","volume":"109","author":"SA McAvoy","year":"2013","unstructured":"McAvoy SA, Ciura KT, Rineer JM, Allen PK, Liao Z, Chang JY, Palmer MB, Cox JD, Komaki R, Gomez DR. Feasibility of proton beam therapy for reirradiation of locoregionally recurrent non-small cell lung cancer. Radiother Oncol. 2013;109:38\u201344.","journal-title":"Radiother Oncol"},{"key":"673_CR28","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.radonc.2013.03.015","volume":"107","author":"TR Meijneke","year":"2013","unstructured":"Meijneke TR, Petit SF, Wentzler D, Hoogeman M, Nuyttens JJ. Reirradiation and stereotactic radiotherapy for tumors in the lung: dose summation and toxicity. Radiother Oncol. 2013;107:423\u20137.","journal-title":"Radiother Oncol"},{"key":"673_CR29","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/1748-717X-8-99","volume":"8","author":"M Reyngold","year":"2013","unstructured":"Reyngold M, Wu AJ, McLane A, Zhang Z, Hsu M, Stein NF, Zhou Y, Ho AY, Rosenzweig KE, Yorke ED, Rimner A. Toxicity and outcomes of thoracic re-irradiation using stereotactic body radiation therapy (SBRT). Radiat Oncol. 2013;8:99.","journal-title":"Radiat Oncol"},{"key":"673_CR30","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s10147-005-0501-1","volume":"10","author":"T Tada","year":"2005","unstructured":"Tada T, Fukuda H, Matsui K, Hirashima T, Hosono M, Takada Y, Inoue Y. Non-small-cell lung cancer: reirradiation for loco-regional relapse previously treated with radiation therapy. Int J Clin Oncol. 2005;10:247\u201350.","journal-title":"Int J Clin Oncol"},{"key":"673_CR31","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1097\/JTO.0b013e31825f22ce","volume":"7","author":"N Trakul","year":"2012","unstructured":"Trakul N, Harris JP, Le QT, Hara WY, Maxim PG, Loo Jr BW, Diehn M. Stereotactic ablative radiotherapy for reirradiation of locally recurrent lung tumors. J Thorac Oncol. 2012;7:1462\u20135.","journal-title":"J Thorac Oncol"},{"key":"673_CR32","doi-asserted-by":"crossref","unstructured":"Peulen H, Karlsson K, Lindberg K, Tullgren O, Baumann P, Lax I, Lewensohn R, Wersall P. Toxicity after reirradiation of pulmonary tumours with stereotactic body radiotherapy. Radiother Oncol. 2011;101:260\u20136.","DOI":"10.1016\/j.radonc.2011.09.012"},{"key":"673_CR33","doi-asserted-by":"crossref","unstructured":"Timmerman R, McGarry R, Yiannoutsos C, Papiez L, Tudor K, DeLuca J, Ewing M, Abdulrahman R, DesRosiers C, Williams M, Fletcher J. Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J Clin Oncol. 2006;24:4833\u20139.","DOI":"10.1200\/JCO.2006.07.5937"},{"key":"673_CR34","unstructured":"Halperin EC, et al. Perez & Brady\u2019s Principlesand Practice of Radiation Oncology. sixth ed. Philadelphia: Lippincott Williams &Wilkins; 2013."}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-016-0673-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T15:44:27Z","timestamp":1498319067000},"score":1,"resource":{"primary":{"URL":"http:\/\/ro-journal.biomedcentral.com\/articles\/10.1186\/s13014-016-0673-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,2]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["673"],"URL":"https:\/\/doi.org\/10.1186\/s13014-016-0673-z","relation":{},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,2]]},"article-number":"104"}}